PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+3.47%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$1.26B
AUM Growth
+$28.6M
(+2.3%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
28.32%
Holding
1,906
New
457
Increased
363
Reduced
474
Closed
451
Top Buys
| 1 |
CA
CA, Inc.
CA
|
+$33.2M |
| 2 |
Dell
DELL
|
+$32.7M |
| 3 |
DNB
Dun & Bradstreet
DNB
|
+$29.6M |
| 4 |
ANDV
Andeavor
ANDV
|
+$21.1M |
| 5 |
P
Pandora Media Inc
P
|
+$18.2M |
Top Sells
| 1 |
XL
XL Group Ltd.
XL
|
+$38M |
| 2 |
VR
Validus Hold Ltd
VR
|
+$20.3M |
| 3 |
NXP Semiconductors
NXPI
|
+$18.3M |
| 4 |
PAY
Verifone Systems Inc
PAY
|
+$15.4M |
| 5 |
RSPP
RSP Permian, Inc.
RSPP
|
+$13.7M |
Sector Composition
| 1 | Technology | 20.07% |
| 2 | Healthcare | 13.42% |
| 3 | Financials | 11.51% |
| 4 | Communication Services | 11.49% |
| 5 | Energy | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Autodesk
ADSK
$68B
| $840K | 0.05% |
+5,383
| New | +$840K |
|
252
Fortinet
FTNT
$61.1B
| $839K | 0.05% |
45,460
+6,530
| +17% | +$121K |
|
253
Ionis Pharmaceuticals
IONS
$10.1B
| $834K | 0.05% |
+16,174
| New | +$834K |
|
254
Timken Company
TKR
$5.4B
| $818K | 0.05% |
16,418
-24,262
| -60% | -$1.21M |
|
255
MGM Resorts International
MGM
$9.4B
| $813K | 0.05% |
29,139
+19,643
| +207% | +$548K |
|
256
HF Sinclair
DINO
$9.56B
| $801K | 0.05% |
+11,463
| New | +$801K |
|
257
Corcept Therapeutics
CORT
$7.68B
| $796K | 0.05% |
56,769
-1,000
| -2% | -$14K |
|
258
Heron Therapeutics
HRTX
$193M
| $791K | 0.05% |
24,986
-8,762
| -26% | -$277K |
|
259
Western Digital
WDC
$33.9B
| $787K | 0.05% |
17,793
+7,011
| +65% | +$310K |
|
|
ECYT
260
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $786K | 0.05% |
44,284
-7,969
| -15% | -$141K |
|
|
GAP
261
The Gap, Inc.
GAP
$8.5B
| $785K | 0.05% |
+27,193
| New | +$785K |
|
262
RH
RH
$4.08B
| $770K | 0.04% |
5,877
+3,835
| +188% | +$502K |
|
|
IDTI
263
DELISTED
Integrated Device Technology I
IDTI
| $767K | 0.04% |
+16,311
| New | +$767K |
|
264
Procter & Gamble
PG
$370B
| $762K | 0.04% |
9,161
-10,257
| -53% | -$853K |
|
265
Gen Digital
GEN
$17.9B
| $761K | 0.04% |
+35,745
| New | +$761K |
|
266
MSCI
MSCI
$45.1B
| $758K | 0.04% |
4,272
+1,363
| +47% | +$242K |
|
|
NVTA
267
DELISTED
Invitae Corporation
NVTA
| $753K | 0.04% |
+44,994
| New | +$753K |
|
|
NFX
268
DELISTED
Newfield Exploration
NFX
| $751K | 0.04% |
26,050
-137,059
| -84% | -$3.95M |
|
269
Core Laboratories
CLB
$581M
| $731K | 0.04% |
6,308
-223
| -3% | -$25.8K |
|
270
Sangamo Therapeutics
SGMO
$152M
| $725K | 0.04% |
42,759
| – | – |
|
271
NVIDIA
NVDA
$4.33T
| $721K | 0.04% |
102,560
-1,309,720
| -93% | -$9.21M |
|
|
BPMC
272
DELISTED
Blueprint Medicines
BPMC
| $716K | 0.04% |
9,172
+5,593
| +156% | +$437K |
|
|
ADAP
273
Adaptimmune Therapeutics
ADAP
$14.8M
| $715K | 0.04% |
52,759
-139
| -0.3% | -$1.88K |
|
|
VRE
274
Veris Residential
VRE
$1.49B
| $712K | 0.04% |
33,504
+4,069
| +14% | +$86.5K |
|
|
CMBT
275
CMB.TECH NV
CMBT
$2.8B
| $702K | 0.04% |
80,645
-64,085
| -44% | -$558K |
|